Healthcare -
Biotechnology - NASDAQ - US
$ 19.6
1.34 %
$ 3.27 B
Market Cap
14.41
P/E
ACAD - COST OF REVENUE
Cost of Revenue ACAD - ACADIA Pharmaceuticals Inc.
45.7 M
LAST VALUE
54.57%
2 YEAR CAGR
20.06%
5 YEAR CAGR
5.52%
10 YEAR CAGR